Aptevo Therapeutics Inc.APVONASDAQ
Loading
Year-over-year earnings per share growth rate
| Period | Value |
|---|---|
| Q3 2025 | 73.47% |
| Q2 2025 | 90.44% |
| Q1 2025 | -1.52% |
| Q4 2024 | 75.81% |
| Q3 2024 | 71.07% |
| Q2 2024 | 83.21% |
| Q1 2024 | 25.41% |
| Q4 2023 | 39.78% |
| Q3 2023 | 58.93% |
| Q2 2023 | -410.50% |
| Q1 2023 | 155.01% |
| Q4 2022 | 52.19% |
| Q3 2022 | -126.93% |
| Q2 2022 | 457.69% |
| Q1 2022 | -21.74% |
| Q4 2021 | 10.48% |
| Q3 2021 | 18.20% |
| Q2 2021 | -6.47% |
| Q1 2021 | 4.52% |
| Q4 2020 | 18.12% |
| Q3 2020 | 0.18% |
| Q2 2020 | 39.85% |
| Q1 2020 | 93.49% |
| Q4 2019 | -2405.98% |
| Q3 2019 | 48.15% |
| Q2 2019 | 45.82% |
| Q1 2019 | 12.35% |
| Q4 2018 | -12.35% |
| Q3 2018 | 4.78% |
| Q2 2018 | 7.49% |
| Q1 2018 | -37.01% |
| Q4 2017 | -1104.56% |
| Q3 2017 | -2.98% |
| Q2 2017 | -2675.83% |
| Q1 2017 | -2299.96% |
| Q4 2016 | 79.15% |
| Q3 2016 | 99.92% |
| Q2 2016 | -8.58% |
| Q1 2016 | 33.91% |
| Q4 2015 | -41.15% |